Roth Capital Downgrades Sciele Pharma (SCRX) to Hold
Tweet Send to a Friend
Roth Capital downgrades Sciele Pharma (Nasdaq: SCRX) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
